Liquidia (LQDA) Operating Leases (2019 - 2026)
Liquidia's (LQDA) quarterly Operating Leases came in at $6.2 million in Q1 2026, down 5.09% year-on-year from $6.5 million in Q1 2025, and up 0.85% quarter-over-quarter from $6.1 million in Q4 2025.
Liquidia (LQDA) Operating Leases (2019 - 2026) Analysis & Trends
Liquidia's Operating Leases history runs 8 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 5.09% year-over-year to $6.2 million in Q1 2026; TTM through Mar 2026 was $6.2 million, a 5.09% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 7.39% from the prior year.
- Operating Leases climbed to $6.2 million in Q1 2026 per LQDA's latest filing, from $6.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $6.6 million in Q4 2024 and bottomed at $1.4 million in Q3 2024.
- The 5-year median for Operating Leases is $3.6 million (2022), against an average of $4.0 million.
- Across the five-year window, Operating Leases sank 43.96% in 2024 and soared 333.91% in 2025, its largest moves.
- Year by year, Operating Leases stood at $3.3 million in 2022, then decreased by 29.05% to $2.4 million in 2023, then soared by 178.6% to $6.6 million in 2024, then declined by 7.39% to $6.1 million in 2025, then climbed by 0.85% to $6.2 million in 2026.
- Per Business Quant, the three latest LQDA Operating Leases figures stand at $6.2 million (Q1 2026), $6.1 million (Q4 2025), and $6.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.15 Mn |
| Dec 31, 2025 | 6.10 Mn |
| Sep 30, 2025 | 6.26 Mn |
| Jun 30, 2025 | 6.37 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Dec 31, 2024 | 6.59 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 2.36 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 3.33 Mn |
| Sep 30, 2022 | 3.57 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 4.02 Mn |
| Dec 31, 2021 | 4.23 Mn |
| Sep 30, 2021 | 4.44 Mn |
| Jun 30, 2021 | 4.63 Mn |